Outsourcing Directory

Gauthier Biomedical Inc.





Company Headquarters

2221 Washington Street
Grafton, WI 53024
United States

Company Description

Inventor and first company to market ultra-precise ratcheting screwdrivers—t he only design that provides a smooth, accurate ratchet feel, strong torque capability and virtually no play. Premium multi-colored silicone over molded instrumentation featuring logos for impactful branding. With a patented process for combining multiple silicone colors, Gauthier's premium instruments, like the G10 handle family, have for many years been an identifiable symbol of Gauthier's commitment to quality. The U.S. Patent and Trademark Office issued Trademark Registration No. 5,478,595 covering handles of the company's G10 premium branded handle line. The silicone-molded handle family allows OEMs to distinguish themselves by offering ergonomic, customized handles and instruments. Gauthier recently received FDA 510(k) clearance to market its Intellitorq® electronic torque indicator, marking the first 510(k) clearance for such a device. The manual driver, called ITQ® for short, is designed to accurately indicate a preset torque value using LED lights and haptic feedback. FDA registered. ISO 13485:2016

Outsourcing Directory

    Related Content

    • Diagnostics | Neurological
      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      RSNA News: MaxQ AI to Offer Accipio Applications on Blackford Platform

      Represents cost savings and increased quality of care.
      MaxQ AI 12.04.19

    • Mike on Medtech: The Special 510(k) Program

      Mike on Medtech: The Special 510(k) Program

      Mike Drues and Sean Fenske discuss a 510(k) option for modifications to a company's legally marketed medical device.
      Sean Fenske, Editor-in-Chief 11.13.19

    • Cardiovascular | Neurological
      Anaconda Biomed Completes First-in-Human Study of Thrombectomy System

      Anaconda Biomed Completes First-in-Human Study of Thrombectomy System

      Trial Data will support regulatory submission to FDA.
      Business Wire 11.05.19


    • Attune Medical Issued Additional Patent, Acquires License From Stanford University

      Attune Medical Issued Additional Patent, Acquires License From Stanford University

      The license is for a Transesophageal Heat Exchange Catheter for cooling of the heart.
      Business Wire 11.05.19

    • Fiasp Approved for Use with the Omnipod System in the U.S.

      Fiasp Approved for Use with the Omnipod System in the U.S.

      An ultra-fast-acting insulin developed by Novo Nordisk.
      Insulet Corporation 10.29.19

    • Packaging & Sterilization
      Top Surgeons Write Letter to the FDA

      Top Surgeons Write Letter to the FDA

      Stress the importance of Ethylene Oxide for medical device sterilization.
      AdvaMed 10.25.19


    • Cardiovascular
      Corvia Medical

      Corvia Medical's Shunt Device Receives Breakthrough Device Designation

      May reduce symptoms and slow the progression of heart failure.
      PRNewswire 10.09.19

    • Cardiovascular
      Medtronic Stent Graft System Receives FDA Breakthrough Device Designation

      Medtronic Stent Graft System Receives FDA Breakthrough Device Designation

      Developed to treat thoracoabdominal aortic aneurysm.
      Globe Newswire 10.08.19

    • Neurological
      Highmark Interactive Receives FDA Clearance for Gamified Neurological Testing Platform

      Highmark Interactive Receives FDA Clearance for Gamified Neurological Testing Platform

      ‘EQ Brain Performance’ is a tool that addresses cognitive, visual and balance performance.
      Highmark Interactive 10.08.19


    • Surgical
      Top 10 Health Technology Hazards for 2020

      Top 10 Health Technology Hazards for 2020

      The new report identifies safety issues and action steps for 10 dangerous and preventable hazards.
      ECRI Institute 10.07.19

    • Neurological
      Medtronic Submits InterStim Micro Neurostimulator and SureScan MRI Leads to FDA

      Medtronic Submits InterStim Micro Neurostimulator and SureScan MRI Leads to FDA

      Pending approval, the devices could be available Spring 2020.
      Medtronic plc 10.07.19

    • Patient Monitoring
      Medtronic Introduces Envision Pro CGM System in Europe

      Medtronic Introduces Envision Pro CGM System in Europe

      Combines valuable data with optimal user experience.
      Medtronic 09.17.19


    • SyncThink Expands IP With Patent for Content Adaptation to Subject’s Attention Using Eye Tracking

      SyncThink Expands IP With Patent for Content Adaptation to Subject’s Attention Using Eye Tracking

      New patent to allow assessment of a patient’s attention by using eye tracking technology to change the rate of content delivery to match attention levels.
      SyncThink 07.31.19

    • 11. Boston Scientific

      11. Boston Scientific

      AT A GLANCE Rank: #11 (Last year: #11) $9.82 Billion Prior Fiscal: $9.0 Billion Percentage Change: +8% No. of Employees: 32,000 Global Headquarters: Marlborough, Mass. KEY EXECUTIVES Mike Mahoney, Chairman and CEO Daniel J. Brennan, E…
      07.30.19

    • 24. Edwards Lifesciences

      24. Edwards Lifesciences

      AT A GLANCE Rank: #24 (Last year: #23) $3.81 Billion Prior Fiscal: $3.43 Billion Percentage Change:+11.1% No. of Employees: 12,800 Global Headquarters: Irvine, Calif. KEY EXECUTIVES Michael A. Mussallem, Chairman and CEO Scott B. Ulle…
      07.30.19

    • Surgical
      Obalon Makes Moves on First Company-Owned Retail Weight Loss Center

      Obalon Makes Moves on First Company-Owned Retail Weight Loss Center

      The first Obalon retail center will be located in San Diego and the company is targeting this fall for its grand opening.
      GlobeNewswire 07.24.19

    • Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert With CGM and Smart Pens

      Glytec Awarded Patent Allowance for Virtual Insulin Titration in Concert With CGM and Smart Pens

      Company's digital platform offers primary care providers the means to use CGM data to formulate timely and discrete dosing recommendations.
      Business Wire 07.05.19